Diseases, Conditions, Syndromes

Study finds COPD is over-diagnosed among uninsured patients

More than 40 percent of patients being treated for COPD at a federally funded clinic did not have the disease, researchers found after evaluating the patients with spirometry, the diagnostic "gold standard" for chronic obstructive ...

Diseases, Conditions, Syndromes

Tiny, implantable coil promises hope for emphysema patients

A small, easily implantable device called the Lung Volume Reduction Coil (LVRC) may play a key role in the treatment of two types of emphysema, according to a study conducted in Europe. Results of the study indicate the beneficial ...

Health

'Black lung is back' researcher says

The dangers of coal mining enter the spotlight periodically when disasters strike, but one West Virginia University researcher argues that coal mine dust exposure, which has caused an increase in the prevalence and severity ...

Medications

FDA approves once-a-day inhaler from Glaxo

The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.

Medications

US panel backs inhaler drug for lung disease

A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.

Diseases, Conditions, Syndromes

Gene study helps understand pulmonary fibrosis

A new study looking at the genomes of more than 1,500 patients with idiopathic pulmonary fibrosis, a rare and devastating lung disease, found multiple genetic associations with the disease, including one gene variant that ...

Diseases, Conditions, Syndromes

Better communication reduces prescriptions for antibiotics

(HealthDay)—Neither C-reactive protein testing nor enhanced physician communication training resulted in reduced office visits, but enhanced communication training resulted in less prescribing for antibiotics for respiratory ...

page 13 from 32